﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Medical Biochemistry</JournalTitle>
      <Issn>2345-4113</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2020</Year>
        <Month>06</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Identification of the Anti-sickling Activity of Anogeissus leiocarpus and In Silico Investigation of Some of Its Phytochemicals</ArticleTitle>
    <FirstPage>1</FirstPage>
    <LastPage>14</LastPage>
    <ELocationID EIdType="doi">10.34172/ajmb.2020.01</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Taiwo O.</FirstName>
        <LastName>Elufioye</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3888-5110</Identifier>
      </Author>
      <Author>
        <FirstName>Babatunde M.</FirstName>
        <LastName>Williams</LastName>
      </Author>
      <Author>
        <FirstName>Mojisola C.</FirstName>
        <LastName>Cyril-Olutayo</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajmb.2020.01</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>11</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>03</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <Abstract>Background: The anti-sickling activity of Anogeissus leiocarpus, a plant used for managing sickle cell disease (SCD), has been previously proven. Objectives: This study investigated the anti-sickling mechanism of A. leiocarpus by probing its effects on Gardos channel (KCNN4), erythropoietin (EPO), erythropoietin receptor (EPOR), catalase (CAT), G6pD, D-type cyclins and cyclin-dependent kinase inhibitors (p21) gene expression as well as assessing in silico drug-likeness of reported compounds as EPOR agonist. Methods: A total of 18 rats (45-76 g) were selected and divided into 6 groups (n=3). The control group was given water ad libitum, standard group was given 0.1 mL/kg of Ciklavit® and experimental group was given daily oral doses of 50-100 mg/kg body weight of crude methanol extract or ethyl acetate fraction (EA-PF). Haematological parameters were analyzed while histopathological and molecular studies of kidney and bone marrow were carried out, followed by RT-PCR analysis of KCNN4, EPO, EPOR, CAT, G6pD, p21, and cyclin-dependent kinase inhibitors. Docking studies of the reported compounds were also done. Results: EA-PF had an insignificant (P&gt;0.05) effect on haematological parameters compared to the basal group. While CAT and p21 acted in a positive feedback loop, G6pD was downregulated in the experimental groups. KCNN4 acted in a negative-feedback mechanism and the upregulation of EPO and EPOR was followed by increased reticulocytes. Kaempferol, quercetin, and catechin showed non-violation of Lipinski’s rule and high binding affinities of 6.5 kcal/mol, 6.7 kcal/mol, and 6.7 kcal/mol, respectively, for EPOR pocket compared to the co-crystallized ligand. Conclusion: Results suggest that ethyl acetate fraction of Anogeissus leiocarpus achieved a steady state level of the Gardos channel and stimulation of EPO expression via EPOR agonist.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Sickle cell anaemia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Anogeissus leiocarpus</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Gardos channel</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Erythropoiesis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mechanism of action</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>